retatrutide ly3437943 clinical trial results New Phase 3 data just dropped 👀 Eli Lilly's reported average weight loss approaching 30%, with some patients achieving historically associated with bariatric surgery. A few important caveats Triple hormone receptor agonist retatrutide

A rendszeres testmozgs szmos elnnyel jr, tbbek kztt: Fokozott inzulinrzkenysg - A testmozgs javtja a szervezet inzulin hatkony felhasznlsnak kpessgt, cskkentve ezzel a 2-es tpus cukorbetegsg kockzatt

Incretin-based agents in type 2 diabetic patients at cardiovascular risk: compare the effect of GLP-1 agonists and DPP-4 inhibitors on cardiovascular and pancreatic outcomes

At the 82nd Golden Globes on Jan

Patients should be alert to: Persistent constipation , which may increase diverticular pressure New or worsening abdominal pain , especially if localised to the lower abdomen Changes in stool consistency or frequency Fever or systemic symptoms suggesting infection Communication with healthcare providers is vital

2024 May 17 [cited 2025 Oct 21];27(5)

Glucagon receptor stimulation increases hepatic fatty acid oxidation and promotes lipolysis in adipose tissue through GIP receptor activation, creating metabolic conditions that favor fat utilization